EAGAN, Minn. -- There were some nights this season when Minnesota Vikings general manager Kwesi Adofo-Mensah stared at the ceiling. Where had he gone wrong? Why were the Vikings losing so many games ...

The writing has been on the wall as quarterback J.J. McCarthy has struggled with a wide array of problems since taking over as the starter for the Vikings. Not only has he left something to be desired ...

If you're tired of seeing Shorts appear at the top of your YouTube search results, the app's new filter will help you out. YouTube on Thursday said it is adding a Shorts filter under the Type menu.

The Cyberpunk 2077: Fresh Start mod has received a new update, adding a fourth lifepath option that combines both the Corpo and Nomad origins, along with a new prologue. Available on the Nexus Mods ...

First base continues to be a topic surrounding the Washington Nationals this winter. After cutting Nathaniel Lowe in the midst of the 2025 campaign and then letting Josh Bell walk in free agency, the ...

Bloober Team has announced “Temporal Diver Mode,” a new, easier difficulty option coming to third-person survival horror game Cronos: The New Dawn in early 2026. “Cronos: The New Dawn was a game ...

Please provide your email address to receive an email when new articles are posted on . Results of the trial, which compared tucatinib (Tukysa, Seagen) with placebo in combination with trastuzumab ...

SAN FRANCISCO — Right-hander Adrian Houser finalized a $22 million, two-year contract with the San Francisco Giants on Friday that includes a club option for 2028, becoming the second pitcher added to ...

The new offering, expected to go live on 9 February 2026, will expand the cash-settled, European-style options’ current trading hours of 9.30am ET to 4.15pm ET Monday to Friday to also cover an ...

Nov 26 (Reuters) - The Pentagon has concluded that Alibaba Group Holding (9988.HK), opens new tab, Baidu Inc (9888.HK), opens new tab and BYD Co (1211.HK), opens new tab should be added to a list of ...

What Is Caplyta, and Why Does It Matter? Caplyta (lumateperone) is a once-daily oral medicine now approved to be used with antidepressants to treat major depressive disorder (MDD) in adults. It ...